Formic Acid

Formic Acid

SCHEMBL2593345

NC(=O)c1ccc(OCC(F)(F)F)cn1.O=CO

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.53
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
CACNA1G O43497 2/20 0.40
CACNA1H O95180 2/20 0.40
CACNA1I Q9P0X4 2/20 0.40
CNR2 P34972 1/20 0.40
KCNH2 Q12809 1/20 0.40
BACE1 P56817 4/20 0.39
BACE2 Q9Y5Z0 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
P4HTM Q9NXG6 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15994885 0.94 KMT2A (0.58) KMT2AOPRM1OPRD1OPRK1CACNA1G
SCHEMBL287075 0.80 P4HTM (0.58) KMT2ACACNA1GCACNA1HCACNA1ICNR2
SCHEMBL29601148 0.79 CACNA1I (0.45) KMT2ACACNA1GCACNA1HCACNA1ICNR2
SCHEMBL27039792 0.79 CACNA1I (0.45) KMT2ACACNA1GCACNA1HCACNA1ICNR2
SCHEMBL21078924 0.78 CACNA1G (0.42) KMT2ACACNA1GCACNA1HCACNA1ICNR2
SCHEMBL19309297 0.77 KMT2A (0.50) KMT2AOPRM1OPRD1OPRK1BACE1
SCHEMBL17394948 0.77 NPSR1 (0.38) KMT2ACACNA1GCACNA1HCACNA1ICNR2
Formic Acid SCHEMBL2584800 0.77 KMT2A (0.44) KMT2AOPRM1OPRD1OPRK1BACE1
SCHEMBL14480227 0.77 CACNA1I (0.41) KMT2ACACNA1GCACNA1HCACNA1ICNR2
SCHEMBL27039858 0.77 CACNA1G (0.41) KMT2ACACNA1GCACNA1HCACNA1ICNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011138293-A1 2,5,6,7-TETRAHYDRO-[1,4]OXAZEPIN-3-YLAMINE OR 2,3,6,7-TETRAHYDRO-[1,4]OXAZEPIN-5-YLAMINE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-11-10 WO disclosed